- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05584085
ACT-DE for Diabetes Distress and HbA1c in Adults With Type 2 Diabetes (ACT-DE)
The Effects of Acceptance-based Diabetes Education on Diabetes Distress and Glycaemic Control in Adults With Type 2 Diabetes: A Randomised Controlled Trial.
This study will evaluate the effectiveness of a structured acceptance-based diabetes education programme for adults with type 2 diabetes compared with those who received diabetes education. The programme mainly comprises acceptance and commitment therapy (ACT) as a psychological component and a diabetes education (DE) component. The short form of the programme is named 'ACT-DE'. This programme aims to decrease the diabetes distress level in participants with type 2 diabetes and improve their blood glucose level. The objectives are:
- To develop an ACT-based intervention protocol as a guide for promoting healthy coping in people with type 2 diabetes who are psychologically distressed.
- To examine the effects of 'ACT-DE' on diabetes distress and HbA1c (primary outcomes) over a three-month follow-up, when compared with diabetes education only.
- To examine the effects of 'ACT-DE' on diabetes self-management behaviours, self-efficacy in diabetes care, and psychological flexibility (secondary outcomes) over the three-month follow-up, when compared with diabetes education; and
- To identify the relationships between psychological flexibility and diabetes self-efficacy, diabetes self-management behaviour and HbA1c among the study participants
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Diabetes distress is an aversive feeling and emotional disturbance specific to diabetes, including the burden of daily self-care, worry and guilty feelings, and low satisfaction level with health care professionals. Around 36% of people with type 2 diabetes worldwide suffered from diabetes distress, which is associated with poor self-care performance, low self-efficacy in diabetes management and higher blood glucose levels. Acceptance and commitment therapy, one of the mindfulness and acceptance-based interventions, integrated with diabetes education are found to be potentially effective interventions for reducing diabetes distress.
A pilot study has been conducted earlier (NCT05563987) and showed that a six-week ACT-DE programme (5 sessions) was preliminary effective compared to attending only one session of diabetes education. It was also a feasible and acceptable intervention.
In this main study, a convenience sampling method will be adopted from three out-patient clinics of public hospitals in Hong Kong. A total of 176 eligible participants will be randomly allocated into the intervention (N=88) and the control group (N=88). Participants in the intervention group will receive 6-week ACT-DE programme (5 sessions) composing acceptance and commitment therapy and diabetes education. Each session last for 120 minutes in a group of 8-10 participants. Participants in the control group will receive one session of diabetes education.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hong Kong Island
-
Hong Kong, Hong Kong Island, Hong Kong
- Recruiting
- The Nethersole School of Nursing
-
Contact:
- The NSO Nursing
- Phone Number: +85296547323
- Email: annangan@cuhk.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- community-dwelling adults Hong Kong Chinese residents,
- aged 18-64,
- diagnosed with type 2 diabetes for over one year;
- at least moderate level of diabetes distress as measured with the Chinese
- Diabetes Distress Scale (CDDS-15; mean score >2 per item);
- having suboptimal blood glucose control as shown by HbA1c level of ≥ 7% in the laboratory results within the past six months;
- able to communicate in Cantonese and give written consent
Exclusion Criteria:
- history of a clinically diagnosed mental illness such as depression and anxiety disorder, and/or an acute/severe medical disease;
- noticeable cognitive impairment(s) as indicated by the total score (<6 of 10) of the Abbreviated Mental Test;
- recently received/receiving any psychological therapy such as mindfulness or acceptance-based therapy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Acceptance and commitment therapy integrated in diabetes education (ACT-DE)
The proposed intervention is a six-week acceptance-based diabetes education programme (ACT-DE) comprising acceptance and commitment therapy and diabetes education. Session 1: Diabetes education and introduction of ACT-DE programme Session 2: Mindfulness cultivation Session 3: Value clarification Session 4: Integrating ACT into diabetes self-management Session 5: Booster session Session length: 120 minutes Group-based (6-8 participants) and face-to-face mode of delivery |
Acceptance and Commitment Therapy is a third-wave psychological therapy to cultivate participants' acceptance attitude to diabetes and motivate them for a value-driven persistent diabetes self-management, directed by six psychological processes in the ACT hexagonal model, including acceptance, cognitive defusion, the present moment, self-as-context, value clarification and committed action.
|
|
PLACEBO_COMPARATOR: Diabetes education
One session of diabetes education, group-based (6-8 participants) and 120 minutes via face-to-face delivery.
|
Acceptance and Commitment Therapy is a third-wave psychological therapy to cultivate participants' acceptance attitude to diabetes and motivate them for a value-driven persistent diabetes self-management, directed by six psychological processes in the ACT hexagonal model, including acceptance, cognitive defusion, the present moment, self-as-context, value clarification and committed action.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline Diabetes Distress Scale at 3 months post intervention
Time Frame: Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
Diabetes distress will be measured by the Chinese 15-item Diabetes Distress Scale (CDDS-15). It consists of 15 items. rated on a six-point Likert scale from 1 = 'not a problem' to 6 = 'a serious problem'. A mean item score of 2-2.9 and ≥3.0 indicates moderate and severe distress, respectively. |
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
|
Change from baseline HbA1c at 3 months post-intervention
Time Frame: Baseline (T0), and 3-month post-intervention (T2)
|
Blood glucose level of participants will be evaluated with an HbA1c level, which measures the average blood glucose level during the past three months.
An HbA1c level over 7% is considered suboptimal glycaemic control, indicating a high risk of diabetes complications.2
HbA1c values obtained every 3-4 months will be collected from the patient electronic information system.
|
Baseline (T0), and 3-month post-intervention (T2)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diabetes self-management behaviours
Time Frame: Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
was measured by the Chinese version of diabetes self-management activities (C-SDSCA).
It has 11 items rated on an eight-point Likert scale from 0 to 7, with higher scores indicating more attention to self-management activities.
|
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
|
Diabetes management self-efficacy
Time Frame: Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
was measured by the Chinese version of Diabetes Management Self-Efficacy Scale (C-DMSES).
The C-DMSES contains 20 items rated on an 11#point Likert scale, in which zero indicates not at all confident, and 10 indicates very confident.
|
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
|
Psychological flexibility
Time Frame: Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
was measured by the Chinese version of the Acceptance and Action Questionnaire (AAQ-II Chinese). It contains seven items rated on a seven-point, agreement-based response scale from 1 = 'never true' to 7 = 'always true'. The - Page 3 of 5 - AAQ-II will be scored by summing all item responses, with higher scale scores indicating a greater psychological inflexibility. |
Baseline (T0), immediate post-intervention (T1) and 3-month post-intervention (T2)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACT-DE for DD and HbA1c
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acceptance and Commitment Therapy
-
Istanbul University - CerrahpasaRecruitingAcceptance and Commitment TherapyTurkey
-
Southern Methodist UniversityCompleted
-
University of AarhusRecruitingFocused Acceptance and Commitment Therapy (FACT) | WailistDenmark
-
The University of Hong KongNew Life Psychiatric Rehabilitation AssociationRecruitingAcceptance and Commitment Therapy | Psychological Well-beingHong Kong
-
University of Social Sciences and Humanities, WarsawNational Science Centre, PolandRecruitingHematopoietic Cell Transplantation Recipient | Acceptance and Commitment TherapyPoland
-
Western Michigan UniversityCompletedAcceptance and Commitment Therapy | Supportive Therapy
-
National Taiwan University HospitalRecruitingAcceptance and Commitment Therapy | Oncology Nurse | Psychological SupportTaiwan
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPhysical Activity | Exercise | Behavior | Lifestyle | Acceptance and Commitment Therapy | ACT | Lifestyle, SedentaryUnited States
-
Necmettin Erbakan UniversityNot yet recruitingCaregiver Burden | Acceptance and Commitment Therapy | Pediatric Palliative CareTurkey (Türkiye)
-
University of AlcalaHospital Universitario Principe de AsturiasCompletedPanic Disorder | Acceptance and Commitment Therapy | Predictor | Cognitive-Behavioral TherapySpain
Clinical Trials on ACT-DE
-
Chinese University of Hong KongCompletedType 2 Diabetes | Acceptance and Commitment Therapy | Diabetes DistressHong Kong
-
Medwave Estudios LimitadaAsociación Chilena de SeguridadUnknownOccupational Exposure | Musculoskeletal DiseaseChile
-
Idorsia Pharmaceuticals Ltd.Completed
-
Azusa Pacific UniversityWithdrawnAnxiety Disorders | Stress Disorders, Traumatic | AnxietyUnited States
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsNetherlands
-
Idorsia Pharmaceuticals Ltd.Terminated
-
Idorsia Pharmaceuticals Ltd.CompletedPharmacokinetics | Pharmacodynamics | Tolerability | SafetyNetherlands
-
Karolinska InstitutetRegion Stockholm; Forte; Stiftelsen Frimurarna BarnhusetActive, not recruitingDepression | Stress, Psychological | Intellectual Disability | Anxiety | Neurodevelopmental Disorders | Traumatic Brain Injury | Autism Spectrum Disorder | Parents | Attention Deficit Hyperactivity Disorder | Physical DisabilitySweden
-
University of CoimbraFundação para a Ciência e a TecnologiaUnknown